No Photo Available

Last Update

2016-09-30T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Max Link?

Dr. Max E. Link

HQ Phone: (301) 309-8504

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Human Genome Sciences , Inc.

14200 SHADY GROVE RD

Rockville, Maryland 20850

United States

Company Description

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer and other imm ... more

Find other employees at this company (597)

Background Information

Employment History

Chairman and Chief Executive Officer

Centerpulse AG

Executive Vice President

Finance

Chairman of Directors

Seeking Alpha Inc

Chairman of Directors

MiV Investments Inc

Chief Executive Officer

Sandoz Inc

Director

Celsion Corporation

Affiliations

Chairman
CytRx Corporation

Director
Access Pharmaceuticals , Inc.

Director
Cell Therapeutics , Inc.

Director
Protein Design Labs , Inc.

Board Member
Mipharm S.p.A.

Scientific Advisor
Excalibur Fund Managers Limited

Board Member
Enobia Pharma Inc.

Board Member
BioSpecifics Technologies Corp.

Chairman of Board of Directors for Amedica Corporation
Creation Capital LLC

Board Member
Committee Composition

Board Member
ESP Pharma , Inc.

Board Member
ORTHOsoft Inc

Board Member
International Longevity Center

Supervisory Board Member
Affectis Pharmaceuticals AG

Member of Advisory Board
NGN Capital LLC

Board Member
Selected Past Portfolio

Member of Supervisory Board
Igeneon AG

Member of Audit Committee, Committee Chair for Compensation Committee
Nominating Committee and Governance

Member
Audit Committee

Board Member
Golden Capital Securities Ltd

Board Member
Rx MarketPlace

Board Member
Novuspharma SpA

Director
Alexion Pharmaceuticals Inc

Director
Discovery Laboratories , Inc.

Education

Ph.D.

Economics

University of St. Gallen

Ph.D.

Economics

University of St.Gallen , Switzerland

PhD

Economics

University of St-Gallen

doctoral degree

Economics

University of St. Gallen

Web References (180 Total References)


Arthurian – Dr Max Link

arthurianlifesciences.co.uk [cached]

Dr Max Link

...
Dr Max Link
...
Dr Max Link
...
Max is a highly experienced executive director and non-executive director in the industry. A former CEO of Sandoz Pharma, he served as chairman of the CytRX Corporation, Alexion Pharmaceuticals Inc., the Celsion Corporation and director of Discovery Laboratories Inc. Max was also a director of Access Pharmaceuticals, Inc., Cell Therapeutics, Inc., Columbia Laboratories, Inc., Human Genome Sciences, Inc. and Protein Design Laboratories, Inc. From 2002 to 2004, he was chairman and CEO of Sulzer Medica, Europe's largest orthopaedic company and supervised the sale to Zimmer for $3.3bn. Max has been chairman of Merlin General Partner Funds II and III for 10 Years.


CytRx - Investor Relations - Biography

phx.corporate-ir.net [cached]

Max  Link, Ph.D. CytRx - Investor Relations - Biography

...
Max  Link, Ph.D. Chairman of the Board
Dr. Link has been a director since 1996. Dr. Link has been retired from business since 2003. From March 2002 until its acquisition by Zimmer Holdings, Dr. Link served as Chairman and CEO of Centerpulse, Ltd. From May 1993 to June 1994, Dr. Link served as the Chief Executive Officer of Corange Ltd. (the holding company for Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy International). From 1992 to 1993, Dr. Link was Chairman of Sandoz Pharma, Ltd. From 1987 to 1992, Dr. Link was the Chief Executive Officer of Sandoz Pharma and a member of the Executive Board of Sandoz, Ltd., Basel. Prior to 1987, Dr. Link served in various capacities with the U.S. operations of Sandoz, including President and Chief Executive Officer. Dr. Link also serves as a director of Alexion Pharmaceuticals, Inc., Celsion Corporation and Discovery Laboratories, Inc., each of which is a public company.


Alexion Pharmaceuticals - Board of Directors

www.alxn.com [cached]

Max Link, Ph.D. Chairman of the Board of Directors

Max Link, Ph.D. has been the Chairman of our board of directors since December 2002 and a director of Alexion since April 1992. From March 2001 to September 2003, Dr. Link was Chairman of the Board and CEO of Centerpulse AG, a medical implant company. From May 1993 to June 1994, Dr. Link was Chief Executive Officer of Corange (Bermuda), the parent company of Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy Orthopedics. From 1992 to 1993, Dr. Link was Chairman of the Board of Sandoz Pharma, Ltd., a manufacturer of pharmaceutical products. From 1987 to 1992, Dr. Link was the Chief Executive Officer of Sandoz Pharma and a member of the Executive Board of Sandoz, Ltd., Basel. Prior to 1987, Dr. Link served in various capacities with the United States operations of Sandoz, including as President and Chief Executive Officer. Dr. Link is a director of Discovery Labs, Inc. and Human Genome Sciences, Inc., each a publicly held pharmaceutical and/or life-science company. Dr. Link holds a Ph.D. in economics from University of St. Gallen (Switzerland).


board-members - Aeon Scientific

www.aeon-scientific.com [cached]

“We are happy and honoured to welcome Max Link and Gerd Meyer to our board of directors.

...
Besides his role as Chairman of the Board of Aeon Scientific AG, Dr. Max Link has been the Chairman of the Board of Alexion since December 2002. From March 2001 to September 2003, Dr. Link was Chairman of the Board and CEO of Centerpulse AG, a medical implant company. From May 1993 to June 1994, Dr. Link was Chief Executive Officer of Corange (Bermuda), the parent company of Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy Orthopedics. From 1992 to 1993, Dr. Link was Chairman of the Board of Sandoz Pharma, Ltd., a manufacturer of pharmaceutical products. From 1987 to 1992, Dr. Link was the Chief Executive Officer of Sandoz Pharma and a member of the Executive Board of Sandoz, Ltd., Basel. Prior to 1987, Dr. Link served in various capacities with the United States operations of Sandoz, including as President and Chief Executive Officer. Dr. Link is a director of Discovery Labs, Inc. and Human Genome Sciences, Inc., each a publicly held pharmaceutical and/or life-science company. Dr. Link holds a Ph.D. in economics from University of St. Gallen.Â


Max Link, Ph.D. (72), our ...

www.sec.gov [cached]

Max Link, Ph.D. (72), our Chairman of the Board, has been a director since 1996. Dr. Link has been retired from business since 2003. From March 2002 until its acquisition by Zimmer Holdings, Dr. Link served as Chairman and CEO of Centerpulse, Ltd.  From May 1993 to June 1994, Dr. Link served as the Chief Executive Officer of Corange Ltd. (the holding company for Boehringer Mannheim Therapeutics, Boehringer Mannheim Diagnostics and DePuy International). From 1992 to 1993, Dr. Link was Chairman of Sandoz Pharma, Ltd. From 1987 to 1992, Dr. Link was the Chief Executive Officer of Sandoz Pharma and a member of the Executive Board of Sandoz, Ltd., Basel. Prior to 1987, Dr. Link served in various capacities with the United States operations of Sandoz, including President and Chief Executive Officer. Dr. Link currently serves as a director of Alexion Pharmaceuticals, Inc. and Celsion Corporation, Inc., and has previously served on the Boards of Directors of Cell Therapeutics, Inc., Columbia Laboratories, Inc., Human Genome Sciences, Inc., Protein Design Laboratories and Discovery Laboratories, Inc., each a listed public company.

Dr. Link has extensive executive-level experience with a number of large pharmaceutical companies, including Sandoz Pharma, Ltd.  In these positions, he was responsible for major strategic and other business initiatives, including new drug development, acquisitions and dispositions of new drug candidates and other technology, licensing, marketing and distribution agreements and other key contractual strategic arrangements that affect, or are likely to affect, our company's own business efforts.  As an executive officer and board member of these other companies, he has experience with the regulatory schemes in foreign jurisdictions and also has been exposed to different approaches to corporate governance matters, potential conflicts of interest, and similar matters, which enables him to offer importance guidance to our board of directors.

Similar Profiles

Other People with this Name

Other people with the name Link

David Link
Moose International Inc

Joshua Link
AnnieMac Home Mortgage

Scott Link
NADAP Inc

Brandi Link
King County

Wendy Sartory Link
Ackerman , Link & Sartory , P.A.

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory